Picard Medical, Inc. (NYSE American: PMI) (the 'Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, ...
MedPage Today on MSN
The Chase Is Still On in Heart Pump Innovation
New concepts in device therapy for advanced heart failure presented in early reports ...
People who work at night have a higher risk of coronary artery disease, a type of heart disease. A new study suggests that a higher fibre intake in the diet may help reduce this risk.
New data highlight additional benefits beyond survival with the SynCardia Total Artificial Heart and preclinical progress for the next-generation Emperor system ...
Västerås, Sweden, March 4 2026 - Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval in India. The patent covers a control method and system configura ...
16don MSN
A cardiac surgeon ignored his own heart attack symptoms. He says anyone can miss the red flags.
A cardiac surgeon thought he was in great shape. After a surprising heart attack, he noticed subtle risk factors in his routine and made changes.
Invitation-only program at Houston Methodist, one of the top heart transplant centers in the U.S., highlights the growing need for SynCardia ...
Wellbeing Magazine on MSN
The connection between circulation and overall wellbeing: Why vascular health matters more than you think
Introduction: The Invisible System That Sustains Life When most people think about wellbeing, they think of diet or exercise, sleep, and mental health. Circulation seldom makes the headlines in ...
New research suggests that adding just one tablespoon of "liquid gold" to your morning ritual could slash your risk of heart ...
Imagine an animal that can regrow its whole body — head, brain, organs, and all — from just a small fragment.
As 20 million pregnancies worldwide are classified as high-risk annually, AI technology supports more consistent prenatal monitoring SEOUL, SOUTH KOREA / ACCESS Newswire / March 9, 2026 / Artificial ...
TransMedics continues to reinvent the organ transplant industry, but the market insists the stock is "overvalued" now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results